Business Standard

Eye-care chain Dr Agarwal's Healthcare raises Rs 270 cr from Temasek

Investment will be used to expand Indian operations, acquire latest technology for super specialty eye care; firm plans to double number of hospitals to 150, treble turnover to Rs 1,500 crore

Dr Agarwal's Eye Hospital
Premium

(Photo courtesy: Wikimedia Commons)

T E Narasimhan Chennai
Leading eye-care chain Dr Agarwal‘s Healthcare Ltd. (DAHCL) has raised Rs 270-crore investment from Temasek, a global investment company headquartered in Singapore. The sovereign fund has taken a minority stake.

The investment will be used to expand the Indian geographical footprint of the international eye-care chain, and acquire latest technology for super specialty eye care, said Amar Agarwal, Chairman, Dr Agarwal’s Group of Eye Hospitals.

The hospital is looking at expanding the number of hospitals to 150 in the next five years from the current 75 now.

Temasek is a global investor anchored in Asia, with India accounting for around

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in